Artelo Biosciences (ARTL) news
Recent news
Trading halted: (Artl) Due to limit-up limit-down trading pause
Trading was temporarily suspended for Artl (ticker: ARTL) on Monday, September 21, 2026, due to a limit-up limit-down condition, according to the exchange. The halt occurred after the stock reached a price threshold that triggered the mechanism designed to prevent excessive volatility and allow for…
AInvest Wire · Sep 23, 2026ArteLo Biosciences - Art27.13 shows no effect on body weight or fat mass in lean mice
AInvest Wire · Sep 16, 2026Artelo Biosciences announces reverse stock split
Artelo Biosciences, Inc. (Nasdaq: ARTL) announced on March 6, 2026, that its Board of Directors approved 3-for-1 reverse stock split , effective March 10, 2026. The move aims to increase the price per share to enhance marketability and liquidity. Following the split, each three shares will be…
AInvest Wire · Aug 27, 2026Artelo Biosciences secures notice of allowance in Japan for patent claims for the intended commercial formulation of ART27.13
Artelo Biosciences, Inc. (Nasdaq: ARTL) has received a Notice of Allowance from the Japanese Patent Office for patent claims covering the intended commercial formulation of its peripherally selective cannabinoid agonist, ART27.13. The allowed claims protect compositions of ART27.13 dispersed in…
AInvest Wire · Aug 20, 2026Artelo Biosciences - patent protection for ART27.13 expected through 2041
Artelo Biosciences, Inc. (Nasdaq: ARTL) has received a Notice of Allowance from the European Patent Office (EPO) for its patent application covering the intended commercial formulation of ART27.13, a peripherally selective cannabinoid agonist under evaluation in a Phase 2 clinical trial for the…
AInvest Wire · Aug 17, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.